$3.11
-$0.06
(-1.89%)
Quote as of 4:00 PM EST on 02/09/12
Orexigen Therapeutics, Inc.
NASDAQ:OREX
|
$3.11
-$0.06
(-1.89%)
|
|
| Today's Open | $3.18 |
|---|---|
| Previous Close | $3.17 |
| Daily Range | $3.08 - $3.18 |
| 52-Week Range | $1.22 - $3.56 |
| Market Cap | $149.54M |
| P/E Ratio | -4.34 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 350,918 |
| Average Daily Volume | 833,823 |
| Current FY EPS | -$0.61 |
OREX Information
| Description |
|---|
| A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Diet Pill Scorecard: Vivus, Arena, Orexigen Still Chasing Market Approvals
Has Arena Pharmaceuticals Become the Perfect Stock?
Don't Believe This Company's Warning
Arena Pharma Files Response to CRL - Analyst Blog
This Biotech's Obese To-Do List Is Done
Working Through the Obese To-Do List in 2011
US Stock Futures: HOT STOCKS TO WATCH
US Stock Futures: HOT STOCKS TO WATCH
Zacks #1 Rank Additions for Thursday - Tale of the Tape
